atropine has been researched along with Sciatica in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartolini, A; Calvani, M; Di Cesare Mannelli, L; Ghelardini, C; Mosconi, L; Nicolai, R; Pacini, A; Toscano, A | 1 |
| HIPP, E | 1 |
2 other study(ies) available for atropine and Sciatica
| Article | Year |
|---|---|
Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
Topics: Acetylcarnitine; Animals; Apoptosis; Atropine; Caspase 3; Cytochromes c; Disease Models, Animal; In Situ Nick-End Labeling; Male; Mecamylamine; Muscarinic Antagonists; Neuroprotective Agents; Nicotinic Antagonists; Pain Measurement; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sciatica; Time Factors; X-Linked Inhibitor of Apoptosis Protein | 2009 |
[On the treatment of sacral and sciatic pains with Vertebran].
Topics: Atropine; Cardiovascular Agents; Disease; Ergot Alkaloids; Humans; Oxytocics; Pain; Sacrum; Sciatica; Strophanthins | 1962 |